Effects of esophageal varices obliteration by endoscopic variceal sclerotherapy on asialoscintigraphy and liver function test

Hepatology Research

Volumn 22, Issue 1, 2002, Pages 45-51

  Iwata, Kaoru ^a,b   Shijo, Hiroshi ^b   Kamimura, Seiichiro ^a   Uehara, Yuko ^a,b   Kitamura, Yuji ^a   Iida, Takeshi ^a   Okada, Yasuhiro ^a   Akiyoshi, Nobuo ^b   Watanabe, Hiroshi ^b   Sakisaka, Shotaro ^b  

^a FUKUOKA RED CROSS HOSPITAL   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

Author keywords

Asialoscintigraphy; Endoscopic injection sclerotherapy functional reserve; ICG R15; Portosystemic shunt; Serum concentration of total bile acid

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; BILE ACID; GALACTOSYLNEOGLYCOALBUMIN TC 99M; INDOCYANINE GREEN; MONOETHANOLAMINE OLEATE;

ADULT; AGED; ARTICLE; BILE ACID BLOOD LEVEL; CLINICAL ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DATA ANALYSIS; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; FEMALE; HEART; HEPATOBILIARY PARAMETERS; HUMAN; LIVER CELL; LIVER CIRCULATION; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER SCINTISCANNING; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RADIOACTIVITY; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0036120124     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00118-8     Document Type: Article

References (26)

1. The role of sialic acid in determining the survival of glycoprotein in the circulation
2. The binding of desialyated glycoproteins by plasma membranes of liver
3. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins
4. Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes
5. The binding of D-glucosyl-neoglycoproteins to the hepatic asialoglycoprotein receptor
6. Tc-99m-galactosyl-neoglycoalbumin: In vivo characterization of receptor mediated binding to hepatocytes
7. A radiopharmaceutical for the study of the liver: 99mTc-DTPA-asialo-orosomucoid. II: Human dynamic and imaging studies
8. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage
9. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactoseaminetreated rat
10. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma
11. Systemic hemodynamics and serum nitrate levels inpatients undergoing endoscopic variceal ligation
12. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis
13. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Research Society for Portal Hypertension
14. Analysis of hepatofugal flow in portal venous system using ultrasonic Doppler duplex system
15. Venous abnormalities in portal hypertension demonstrated by CT
16. CT evaluation of esophageal varices
17. Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery
18. A new liver functional study using Tc-99mDTPA-galactosyl human serum albumin: Evaluation of the validity of several functional parameters
19. Transection of the oesophagus for bleeding oesophageal varices
20. Receptor index via hepatic asialoglycoprotein receptor imaging: Correlation with chronic hepatocellular damage
21. Evaluation of hepatic function by the blood retention of 99mTc-DTPA-galactosyl-human serum albumin using biexponential regression analysis
22. Portal pressure after prophylactic sclerotherapy in patients with high-risk varices
23. Distal splenorenal shunt versus endoscopic sclerotherapy for long-term management of variceal bleeding
24. Recurrence factors studied by percutaneous transhepatic portography before and after endoscopic sclerotherapy for esophageal varices
25. Risk factors for recurrence of esophageal varices following endoscopic injection sclerotherapy: A multivariate analysis using Cox's proportional hazards model
26. Study of the changes in portal hemodynamics after endoscopic injection sclerotherapy with reference to the variceal recurrence